TítuloTotal HCV core antigen assay: a new marker of HCV viremia and its application during treatment of chronic hepatitis C

Nuestra implicaciones teóricas se centran en el sector de las PBFs, donde se han realizado dos estudios que colaboran de un modo activo y eminentemente

The draft amendments do not operate any more a distinction between different states of emergency; they repeal articles 120, 121and 122 and make it possible for the President to

43 KFKI Research Institute for Particle and Nuclear Physics, Budapest, Hungary. 44 Institute of Nuclear Research ATOMKI,

To identify viral factors associated with the HCV treatment response, we analyzed the pretreatment NS3/4A protease gene quasispecies composition of 56 HCV genotype

This study evaluated the usefulness of baseline FibroScan values for predicting SVR and the occurrence of anemia and other severe adverse events in HCV genotype 1 patients with

We have studied the characteristics of HCV-nAbs through a retrospective study involving 29 HIV/HCV-coinfected patients who achieved sustained virological response (SVR) with peg-

Integrated HIV DNA was quantified by q-PCR in cross- sectional samples from different groups of patients: (1) HIV+ group: HIV-monoinfected patients that had never been in contact

We have evaluated the performance of a deep-sequencing-based HCV subtyping assay, developed for the 454/GS-Junior platform, in comparison with those of two commercial assays